Neuronetics is a medical technology company that designs, develops, and markets products to improve the quality of life for patients with psychiatric disorders. Their first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation to stimulate specific areas of the brain associated with mood. It is the first non-invasive depression treatment cleared by the FDA for patients who have not benefited from prior antidepressant treatment. NeuroStar is an outpatient treatment that promotes neuroplasticity to target depression where it starts — the brain. With over 4.3 million treatments performed to date, NeuroStar is the market leader in Transcranial Magnetic Stimulation (TMS) for the treatment of Major Depressive Disorder.